Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients.
Leukemia
; 35(3): 897-900, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-32661294
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
Chromosomes, Human, Pair 5
/
Biomarkers, Tumor
/
Chromosome Deletion
/
Lenalidomide
/
Mutation
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom